Dr. Mehlhaff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2400 Hartman Ln
Springfield, OR 97477Phone+1 541-334-3350Fax+1 541-284-5198
Education & Training
Albany Medical CenterResidency, Urology, 1990 - 1995- Albany Medical CenterResidency, Surgery, 1990 - 1992
Oregon Health and Science University School of MedicineClass of 1990
Certifications & Licensure
OR State Medical License 1997 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- 46 citationsThe Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients wi...David P. Dearnaley, Daniel Saltzstein, John Sylvester, Lawrence Karsh, Bryan A. Mehlhaff
European Urology. 2020-08-01 - 1 citationsImpact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.Neal D Shore, Bryan A Mehlhaff, Michael S Cookson, Daniel R Saltzstein, Ronald Tutrone
Advances in Therapy. 2023-11-01 - 30 citationsResults of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT).Neal D. Shore, Daniel Saltzstein, Paul Sieber, Bryan A. Mehlhaff, Lawrence Gervasi
Clinical Genitourinary Cancer. 2019-08-06
Press Mentions
Does Immuno-Oncology Therapy Have a Larger Role in the Urology Clinic?June 21st, 2019
Urology-Specific Quality Measures Are ComingAugust 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
